Sandostatin lar and Injection site pruritus - a phase IV clinical study of FDA data
Injection site pruritus is found among people who take Sandostatin lar, especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Sandostatin lar and have Injection site pruritus. It is created by eHealthMe based on reports of 32,332 people who have side effects when taking Sandostatin lar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
32,332 people reported to have side effects when taking Sandostatin lar.
Among them, 96 people (0.3%) have Injection site pruritus.
What is Sandostatin lar?
Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 32,393 Sandostatin lar users for its effectiveness, alternative drugs and more.
What is Injection site pruritus?
Injection site pruritus (severe itching at injection site) is found to be associated with 1,399 drugs and 938 conditions by eHealthMe.
Number of Sandostatin lar and Injection site pruritus reports submitted per year:
Time on Sandostatin lar when people have Injection site pruritus *:
- < 1 month: 14.29 %
- 1 - 6 months: 14.29 %
- 6 - 12 months: 14.29 %
- 1 - 2 years: 57.14 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Injection site pruritus when taking Sandostatin lar *:
- female: 88.42 %
- male: 11.58 %
Age of people who have Injection site pruritus when taking Sandostatin lar *:
- 0-1: 0.0 %
- 2-9: 1.1 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 15.38 %
- 40-49: 23.08 %
- 50-59: 12.09 %
- 60+: 48.35 %
Common drugs people take besides Sandostatin lar *:
- Sandostatin: 31 people, 32.29%
- Afinitor: 22 people, 22.92%
- Synthroid: 22 people, 22.92%
- Cortef: 13 people, 13.54%
- Sertraline: 9 people, 9.38%
- Elavil: 9 people, 9.38%
- Fish Oil: 9 people, 9.38%
- Aimovig: 8 people, 8.33%
- Dilantin: 5 people, 5.21%
- Flovent: 5 people, 5.21%
Common side effects people have besides Injection site pruritus *:
- Diarrhea: 60 people, 62.50%
- Headache (pain in head): 53 people, 55.21%
- Injection Site Pain: 49 people, 51.04%
- Abdominal Pain: 48 people, 50.00%
- Pain: 47 people, 48.96%
- Nausea (feeling of having an urge to vomit): 47 people, 48.96%
- Cough: 45 people, 46.88%
- Rashes (redness): 45 people, 46.88%
- Abdominal Pain Upper: 44 people, 45.83%
- Fatigue (feeling of tiredness): 42 people, 43.75%
Common conditions people have *:
- Neuroendocrine Tumor: 26 people, 27.08%
- Carcinoid Tumor: 20 people, 20.83%
- Pancreatic Neuroendocrine Tumor: 11 people, 11.46%
- High Blood Pressure: 11 people, 11.46%
- Migraine (headache): 10 people, 10.42%
- Uterine Fibroids (benign growths of the muscle inside the uterus): 9 people, 9.38%
- Drowsiness: 6 people, 6.25%
- Pain: 6 people, 6.25%
- Pituitary Tumor Benign: 5 people, 5.21%
- Gout (uric acid crystals building up in the body): 5 people, 5.21%
* Approximation only. Some reports may have incomplete information.
Do you take Sandostatin lar and have Injection site pruritus?Check whether Injection site pruritus is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
Alternative drugs to, pros and cons of Sandostatin lar:
- Sandostatin lar (32,393 reports)
Injection site pruritus treatments and more:
- Injection site pruritus (50,926 reports)
COVID vaccines that are related to Injection site pruritus:
- Injection site pruritus in Moderna COVID Vaccine
- Injection site pruritus in Pfizer BioNTech Covid Vaccine
- Injection site pruritus in Johnson and Johnson Covid Vaccine
How severe was Injection site pruritus and when was it recovered:
Expand to all the drugs that have ingredients of octreotide acetate:
Common drugs associated with Injection site pruritus:
All the drugs that are associated with Injection site pruritus:
- Injection site pruritus (1,399 drugs)
Common conditions associated with Injection site pruritus:
All the conditions that are associated with Injection site pruritus:
- Injection site pruritus (938 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Sandostatin lar) and Sandostatin lar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.